Zott H J, Kästner C, Bansi D, Wallrabe D
Sportmedizinischen Dienst des BdZL der SV Dynamo, Zentralinstitut für Herz-Kreislauf-Forshcung der AdW, Berlin-Buch.
Z Gesamte Inn Med. 1989 Dec 1;44(23):711-4.
In 10 male juvenile hypertensives WHO stage I who are active in sports echocardiographic investigations were performed at rest and on exertion (up to 2 Watt/kg body-weight) without therapy as well as 1 hour after sublingual administration of 20 mg nifedipine and after a six-week treatment with 3 times 20 mg nifedipine a day. 51 normotensives of the same age served as reference test persons. The antihypertensive effect was distinct, but not so expressive as under the beta-blockade. From the behaviour of the heart rate (reduction under permanent therapy) of the stroke volume (increase to the highest step of exertion) and of the reduction of blood-pressure can be concluded to an economizing effect of the central haemodynamics by nifedipine on exertion. Negative inotropic effects could be excluded particularly from the behaviour of the medium circumferential speed of the velocity of the shortening of fibres on exertion. Nifedipine can be recommended for the treatment of bodily active hypertensives, when the administration of beta-blockers is not to be represented.
对10名处于WHO I期的男性青少年高血压患者进行了超声心动图检查,这些患者积极参加体育活动。检查在未进行治疗的静息状态和运动状态(运动强度达2瓦特/千克体重)下进行,同时在舌下含服20毫克硝苯地平后1小时以及每天服用3次、每次20毫克硝苯地平进行为期六周的治疗后进行。51名同年龄的血压正常者作为对照测试对象。硝苯地平的降压效果明显,但不如β受体阻滞剂治疗时那样显著。从心率(长期治疗下降低)、每搏输出量(运动至最高强度时增加)以及血压降低的情况可以推断,硝苯地平在运动时对中心血流动力学具有节约效应。尤其从运动时纤维缩短速度的平均圆周速度变化情况可以排除负性肌力作用。当不能使用β受体阻滞剂时,硝苯地平可推荐用于治疗身体活动型高血压患者。